1-4 of 4
Oliver Hegener, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Evaluation Of a Prospective, Non-Interventional Study On Efficacy and Tolerability Of a New Generation VWF/FVIII Concentrate In The Treatment Of Von Willebrand Disease

Sonja Alesci, MD, Mario Von Depka, Jennifer Feddern, Susan Halimeh, MD, Oliver Hegener, PhD, Janos Kadar, Wolfgang A. Miesbach, MD, PhD, Ulrike Nowak-Göttl, Inge Scharrer, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4775.
https://doi.org/10.1182/blood.V122.21.4775.4775
Published: 2013
Journal Articles

Pharmacokinetic Evaluation of a Newly Introduced Von Willebrand Factor Concentrate At Two London Haemophilia Centres

Oliver Hegener, PhD, Natasha M Wiles, BSc, MBBS, MRCP, MRCPath, Anne Wareing, Bella Madan, MD, MRCP, FRCPath, Steve K Austin, Dr
Journal: Blood
Blood (2012) 120 (21): 3384.
https://doi.org/10.1182/blood.V120.21.3384.3384
Published: 2012
Journal Articles

Descriptive Evaluation of Age-Related Differences in Clinical Manifestation and Treatment of Von Willebrand's Disease in an Open-Label, Prospective, Non-Interventional Study (wilate ® -SET)

Oliver Hegener, PhD, Inge Scharrer, MD, PhD, Jennifer Feddern, Wolfgang A. Miesbach V, MD, PhD, Mario Von Depka, Janos Kadar
Journal: Blood
Blood (2012) 120 (21): 4630.
https://doi.org/10.1182/blood.V120.21.4630.4630
Published: 2012
Journal Articles

A Neonate with Type 3 Von Willebrands Disease and Life Threatening Bleeding Treated Successfully with a FVIII/VWF Concentrate (wilate®)

Oliver Hegener, PhD, Jemma Efford, Jack L Bartram, Lesley Henderson, Kate Khair
Journal: Blood
Blood (2012) 120 (21): 4633.
https://doi.org/10.1182/blood.V120.21.4633.4633
Published: 2012